The biotechnology industry poses a particular challenge to analysis because its origins were
poorly understood or even noticed at the time. The purpose of this paper is to examine and …

This paper explores the ingredients that stimulated the development of the biotechnology
industry in the US and contrasts conditions with those in Europe. It examines relationships …

A comparison is made of the pattern of emergence, survival and growth of small
biotechnology firms in France, Britain and Canada, using surveys in the three countries …

This paper is a study of the process by which industrial clusters form. It identifies the forces of
attraction to new companies to a cluster in biotechnology in the US as it grows. It uses a …

There are various definitions of an entrepreneurial university, yet there is a lack of
agreement about its core components. This article defines the five key characteristics of an …

The 1980s ushered in a new era in technology and economic development policy as a result
of increasing competitive pressure. Start-up companies built around commercializing new …

The global biopharmaceutical industry, with over $70 bn in revenues and 700 publicly listed
firms posting double-digit growth in North America, Europe, and Asia-Pacific in 2006 …

The US Capitol region ranks as one of the important biotech clusters in the US. This article
documents the general dimensions of the innovative milieu and highlights the historical …

New ventures, companies eight years or younger, play a major role in the development of an
emerging, high-technology industry. Corporate-sponsored new ventures (those supported …

--Leo Tolstoy Tolstoy's epigrammatic comparison of families is not as far removed from
research on innovative, high-technology clusters as one might expect. We contend that …